Skip to content

Ayurvedic Management on Lumbar Spondylosis

A Clinical Comparative Study on Effect of Erandamula Ghanavati, Panchatikta Kshira Basti with and without Kati Basti in Katigrah with special reference to Lumbar Spondylosis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015072
Enrollment
80
Registered
2018-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- with controlled systemic disorders

Interventions

Intervention1: Oral administration of Erandamula Ghanavati in the dose of 500 mg tablet 2 BD per day for a period of 30 days, Panchatikta Kshirabasti 240ml. Panchatikta Kshira Basti per anus, once dai

Sponsors

Government Ayurved College Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The Roland-Morris low back pain and disability questionnaire; if RDQ score >5. 2. Radiological changes, degenerative changes in Lumbar spine. 3. Patients having sign and symptoms of Katigrah according to classics. 4. Patient willing and able to participate in the study. 5. Chronic low back pain more than three month

Exclusion criteria

Exclusion criteria: 1) History of any fracture of vertebral joint/ surgical/ diagnostic intervention with reference to affected joints will be excluded. 2) Gross disability in performing daily normal routine i.e. bedridden patient or confined to a wheelchair will be excluded. 3) Patient with co morbidities such as gouty arthritis, rheumatoid arthritis or psoriatic arthritis, tubercular arthritis. 4) Patient with any deformity of hip or back altering the gait and posture of the patient, ankylosing spondylitis, spinal inflammatory disorders. 5) Patient with uncontrolled hypertension (?160/100mm of Hg) and uncontrolled diabetes (Blood sugar level fasting >125mg/dl and post lunch >200mg/dl) will be ruled out. 6) Patient with evidence of malignancy. 7) Patient on prolonged (?6weeks) medication with corticosteroids, non-steroidal anti-inflammatory drug, antidepressants, anti-cholinergic etc. or any drugs that may influence on the outcome of the study. 8) Patient who have a past history of any other systemic disorders will be excluded in doubtful cases. 9) Pregnant / lactating women. 10) Patients who had participated in any other clinical trial since last six months.

Design outcomes

Primary

MeasureTime frame
1. Evaluate the effect of Erandamula Ghanavati, Panchatikta Kshira Basti along with Kati Basti particularly on the Roland and Morris index, low back pain and disability questionnaire and clinical features of Katigrah with special reference to Lumbar Spondylosis. 2. To compare the effect of Erandamula Ghanavati, Panchatikta Kshira Basti along with Kati Basti with Erandamula Ghanavati annd Panchatikta Kshira Basti.Timepoint: 1)Before start of treatment i.e.day zero 2)Duration of Treatment: Erandamula Ghanavati(30 days, Panchatikta Kshira Basti(15 days) Kati Basti(15 days) Effect of all above will be assessed on 16 th day. This will be second assessment. 3)Effect of all above will be assessed on 31rst day. this will be third assessment and will be termed as after treatment.

Secondary

MeasureTime frame
1. To study literature of Katigrah from texts. 2. To study lumbar spondylosis from modern point of view. 3.Standardization of Panchatikta Bharad used Basti. Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Kabra R Prakash

Government Ayurved College and Hospital Nagpur

kabraprakash2711@gmail.com9225226567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026